On this page
Every capital markets transaction runs through a registration statement, and every registration statement runs on financial statements. The SEC reviews the filing, the auditors comfort the numbers, and the underwriters diligence both. The accounting workstream is on the critical path whether anyone planned it that way or not.
We have prepared companies for these filings and audited them under PCAOB standards, so we know what reviewers comment on and what auditors test. The issues below are the recurring ones across S-1s, F-1s, S-4s, F-4s, and Super 8-Ks, each with the answer and what we do about it.
Issue 01
The registration statement landscape: which form, which financialsS-1 / F-1 / S-4 / F-4 / 8-K
The form your transaction uses determines the financial statements, pro formas, and audit standard required, and teams routinely scope the work off the wrong form. A traditional IPO, a merger, a foreign private issuer, and a de-SPAC each take a different path through the rules.
The treatmentForm S-1 is the domestic IPO registration statement: audited annual financial statements, unaudited interim stubs, MD&A, and full Regulation S-X compliance. Form F-1 is its foreign private issuer counterpart, permitting IFRS as issued by the IASB without US GAAP reconciliation. Form S-4 registers securities issued in mergers and exchange offers, including most de-SPAC combinations: it carries financial statements of both companies plus Article 11 pro formas, and doubles as the proxy statement in a merger vote. Form F-4 is the S-4 for foreign private issuers. The Super 8-K is not a registration statement but does a registration statement’s work: within four business days of closing a shell-company combination, it must carry Form 10 level disclosure, including audited target financials and pro formas. Audits supporting any of these are PCAOB audits performed by a registered firm. Scope the financial statement requirements off the form on day one, because each form has its own periods, staleness windows, and content traps.
What we do: We write the form and financial statement requirements memo on day one of the engagement, so the workplan is scoped to the right filing.
From our engagements: The scoping conversation we have most often: a team six weeks from filing discovers the form requires a period, a pro forma, or an acquired-business financial statement nobody planned for. The form memo on day one prevents it.
Issue 02
Age of financial statements: the staleness clockReg S-X 3-12
Registration statements cannot go effective on stale financial statements, and the staleness windows drive the entire deal calendar. Miss a window and the transaction waits for the next set of financials, which in practice can slip a deal by a full quarter.
The treatmentRegulation S-X 3-12 sets the rhythm: audited annual financial statements and the most recent required interim period must be fresh at effectiveness, with interim statements generally going stale on a 134-day cycle (and tighter rules around year-end). Emerging growth companies may present two years of audited financials instead of three in an IPO, a real cost saver, and can omit periods from draft submissions they reasonably believe will not be required at launch. Acquisitions add S-X 3-05: significant acquired businesses require their own audited financial statements, with significance measured on investment, asset, and income tests and a maximum of two years required post-2020 amendments. Build the filing calendar backward from the staleness dates, including the quarter you will be in at pricing, then hold the close process to it. The calendar is an accounting document as much as a banking one.
What we do: We build the filing calendar backward from the staleness dates and manage the close process to it.
Issue 03
Cheap stock: the comment you should expectASC 718
The SEC staff compares your pre-IPO option grants to the offering price in nearly every IPO review. A grant at $4 twelve months before a $16 offering needs an explanation, and the explanation has to be valuation work, not narrative.
The treatmentMaintain contemporaneous 409A valuations for every grant in roughly the twelve to eighteen months before the offering, and build a bridge analysis that walks from each grant-date value to the anticipated offering price: milestones achieved, market movements, probability-of-IPO weighting changes, and marketability discounts unwinding. Where a grant-date value cannot be supported, the correction is additional stock compensation expense, better recognized before filing than restated after a comment. The disclosure side matters too: MD&A critical estimates should explain the valuation methodology and the drivers of the increase to the offering price. Companies that file with the bridge already built typically clear the comment in one response letter.
What we do: We build the grant-by-grant bridge to the offering price and draft the MD&A valuation disclosure before the staff asks.
In a live transaction with one of these open? Talk to us this week, not after the next draft.
Talk to an Expert
Issue 04
Comfort letters and circle-upsAS 6101
Underwriters require comfort letters from the auditors on every underwritten offering, and the letter’s scope depends on preparation the company controls: what is circled in the prospectus, what supports each number, and how recently the interim financials were reviewed.
The treatmentComfort letters under AS 6101 give negative assurance on changes in specified financial statement items after the latest period, but that assurance is only available within 135 days of the most recent audited or reviewed period, which is why the timing of interim reviews is planned around pricing, not the other way around. Every circled number in the offering document needs a tie-out package: the schedule that supports it, reconciled to the audited financials or the accounting records. Non-GAAP measures and operating metrics get agreed-upon procedures at best, so decide early what the underwriters will ask to have comforted. We build the circle-up support as the document is drafted; retrofitting tie-outs during the pricing week is how deals lose days.
What we do: We prepare the circle-up and tie-out packages as the document is drafted and coordinate the review timing so negative assurance is available at pricing.
From our engagements: Our comfort letter work includes the procedural edge cases, like which parties are entitled to receive a letter and what representations they owe under AS 6101, on live underwritten offerings.
Issue 05
Pro forma financial informationArticle 11
Mergers, significant acquisitions, and de-SPACs require Article 11 pro forma financial statements: the combined company as if the transaction had already happened. The 2021 amendments rewrote the adjustment model, and pro formas drafted from old templates draw comments.
The treatmentArticle 11 now permits two adjustment columns: transaction accounting adjustments, which reflect the required accounting for the transaction (purchase accounting, financing, redemptions), and optional autonomous entity adjustments for spin-offs. Forward-looking synergies live only in an optional, clearly separated management’s adjustments presentation with strict conditions. For a de-SPAC, the pro formas typically present multiple redemption scenarios, reflect the reverse recapitalization, and reconcile share counts to the merger agreement. Every adjustment needs a note explaining the calculation, and the columns must tie to the historical statements included elsewhere in the filing. Draft the pro formas with the transaction accounting memo open, because the two documents must agree.
What we do: We prepare the Article 11 pro formas and adjustment notes so they tie to the historical statements and the transaction accounting memo.
Issue 06
The first quarter as a public companyExchange Act
Effectiveness is the start line, not the finish. The first 10-Q lands on a statutory deadline weeks after listing, with reviewed interim financials, full footnotes, MD&A, and certifications, produced by a team that has never run a public close.
The treatmentStand up the quarterly machine before pricing: a close calendar with owners and dates that hits the filing deadline with review time to spare, a disclosure checklist mapped to the interim requirements, auditor review procedures scheduled, EPS mechanics (including any exchange ratio or IPO-driven share changes) automated, and 302 certification support for the officers signing. The first quarter also inherits everything the S-1 promised: segment presentation, non-GAAP definitions, and critical estimates must match the registration statement or explain the change. Companies that treat the first 10-Q as a continuation of the S-1 process file cleanly; companies that disband the IPO team at pricing do not.
What we do: We stand up the close calendar, disclosure checklist, and certification support before pricing, and run the first quarters with you.